Patents by Inventor Dean Ervin Cress

Dean Ervin Cress has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8105825
    Abstract: The present invention relates to the field of biotechnology or genetic engineering. More specifically, the present invention relates to a multiple inducible gene regulation system that functions within cells to simultaneously control the quantitative expression of multiple genes.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: January 31, 2012
    Assignee: Intrexon Corporation
    Inventors: Tarlochan Singh Dhadialla, Dean Ervin Cress, Glenn Richard Carlson, Robert Eugene Hormann, Subba Reddy Palli, Arthur John Kudla, Ronald Phillip Herzig, Jr., Mohan Philip
  • Patent number: 8030067
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: October 4, 2011
    Assignee: Intrexon Corporation
    Inventors: Jianzhong Zhang, Dean Ervin Cress, Subba Reddy Palli, Tarlochan Singh Dhadialla
  • Publication number: 20110097794
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Application
    Filed: September 23, 2010
    Publication date: April 28, 2011
    Applicant: Intrexon Corporation
    Inventors: Jianzhong Zhang, Dean Ervin Cress, Subba Reddy Palli, Tarlochan Singh Dhadialla
  • Patent number: 7919269
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: April 5, 2011
    Assignee: Intrexon Corporation
    Inventors: Jianzhong Zhang, Dean Ervin Cress, Subba Reddy Palli, Tarlochan Singh Dhadialla
  • Publication number: 20110059525
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: June 17, 2010
    Publication date: March 10, 2011
    Applicant: INTREXON CORPORATION
    Inventors: SUBBA REDDY PALLI, MARIANNA ZINOVJEVNA KAPITSKAYA, DEAN ERVIN CRESS
  • Publication number: 20110059530
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: August 20, 2010
    Publication date: March 10, 2011
    Applicant: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Patent number: 7829676
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: November 9, 2010
    Assignee: Intrexon Corporation
    Inventors: Jianzhong Zhang, Dean Ervin Cress, Subba Reddy Palli, Tarlochan Singh Dhadialla
  • Publication number: 20100275281
    Abstract: The present invention relates to the field of biotechnology or genetic engineering. More specifically, the present invention relates to a multiple inducible gene regulation system that functions within cells to simultaneously control the quantitative expression of multiple genes.
    Type: Application
    Filed: February 17, 2010
    Publication date: October 28, 2010
    Applicant: Intrexon Corporation
    Inventors: Tarlochan Singh DHADIALLA, Dean Ervin Cress, Glenn Richard Carlson, Robert Eugene Hormann, Subba Reddy Palli, Arthur John Kudla, Ronald Phillip Herzig, JR., Mohan Philip
  • Patent number: 7807417
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: October 5, 2010
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Patent number: 7776587
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: August 17, 2010
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Publication number: 20100063260
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Application
    Filed: September 3, 2009
    Publication date: March 11, 2010
    Applicant: Intrexon Corporation
    Inventors: Jianzhong Zhang, Dean Ervin Cress, Subba Reddy Palli, Tarlochan Singh Dhadialla
  • Patent number: 7601508
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: October 13, 2009
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Tarlochan Singh Dhadialla, Jianzhong Zhang, Dean Ervin Cress
  • Publication number: 20080301825
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a Group H nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
    Type: Application
    Filed: August 20, 2007
    Publication date: December 4, 2008
    Inventors: Subba Reddy Palli, Mohan Basavaraju Kumar, Dean Ervin Cress, Ted Tsutomu Fujimoto
  • Publication number: 20080235816
    Abstract: The present invention relates to the field of biotechnology or genetic engineering. More specifically, the present invention relates to a multiple inducible gene regulation system that functions within cells to simultaneously control the quantitative expression of multiple genes.
    Type: Application
    Filed: August 20, 2007
    Publication date: September 25, 2008
    Inventors: Tarlochan Singh Dhadialla, Dean Ervin Cress, Glen Marc Richard Carlson, Robert Eugene Hormann, Subba Reddy Palli, Arthur John Kudla, Ronald Phillip Herzig, Mohan Philip
  • Patent number: 7091038
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screetng assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: August 15, 2006
    Assignee: RheoGene, Inc.
    Inventors: Subba Reddy Palli, Marrianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Publication number: 20040235097
    Abstract: The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity.
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Inventors: Jianzhong Zhang, Dean Ervin Cress, Subba Reddy Palli, Tarlochart Singh Dhadialla
  • Publication number: 20040033600
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: September 19, 2002
    Publication date: February 19, 2004
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Publication number: 20020119521
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: September 26, 2001
    Publication date: August 29, 2002
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Publication number: 20020110861
    Abstract: The present invention relates to the field of biotechnology or genetic engineering. More specifically, the present invention relates to a multiple inducible gene regulation system that functions within cells to simultaneously control the quantitative expression of multiple genes.
    Type: Application
    Filed: September 27, 2001
    Publication date: August 15, 2002
    Inventors: Tarlochan Singh Dhadialla, Dean Ervin Cress, Glenn Richard Carlson, Robert Eugene Hormann, Subba Reddy Palli, Arthur John Kudla, Ronald Phillip Herzig, Mohan Philip
  • Publication number: 20010044151
    Abstract: This invention relates to an improved method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene. The improvement resides in a select group of non-steroid ligands which show improved activity over known ligands.
    Type: Application
    Filed: April 12, 2001
    Publication date: November 22, 2001
    Inventors: Glenn Richard Carlson, Dean Ervin Cress, Tarlochan Singh Dhadialla, Robert Eugene Hormann, Dat Phat Le